» Articles » PMID: 19464092

Meningococcal Carriage and Disease--population Biology and Evolution

Overview
Journal Vaccine
Date 2009 May 26
PMID 19464092
Citations 190
Authors
Affiliations
Soon will be listed here.
Abstract

Meningococcal disease occurs worldwide with incidence rates varying from 1 to 1000 cases per 100,000. The causative organism, Neisseria meningitidis, is an obligate commensal of humans, which normally colonizes the mucosa of the upper respiratory tract without causing invasive disease, a phenomenon known as carriage. Studies using molecular methods have demonstrated the extensive genetic diversity of meningocococci isolated from carriers, in contrast to a limited number of genetic types, known as the hyperinvasive lineages, associated with invasive disease. Population and evolutionary models that invoke positive selection can be used to resolve the apparent paradox of virulent lineages persisting during the global spread of a non-clonal and normally commensal bacterium. The application of insights gained from studies of meningococcal population biology and evolution is important in understanding the spread of disease, as well as in vaccine development and implementation, especially with regard to the challenge of producing comprehensive vaccines based on sub-capsular antigens and measuring their effectiveness.

Citing Articles

Characterization of Unusual Serogroups of .

Taha S, Fantoni G, Hong E, Terrade A, Doucoure O, Deghmane A Microorganisms. 2025; 12(12.

PMID: 39770731 PMC: 11676732. DOI: 10.3390/microorganisms12122528.


Genetic characterization of isolates recovered from patients with invasive meningococcal disease in Lithuania.

Slavinska A, Kowalczyk M, Kirkliauskiene A, Vizuje G, Siedlecki P, Bikulciene J Front Cell Infect Microbiol. 2024; 14:1432197.

PMID: 39469455 PMC: 11513629. DOI: 10.3389/fcimb.2024.1432197.


Evolutionary dynamics of the successful expansion of pandemic Vibrio parahaemolyticus ST3 in Latin America.

Campbell A, Gavilan R, Abanto Marin M, Yang C, Hauton C, van Aerle R Nat Commun. 2024; 15(1):7828.

PMID: 39244587 PMC: 11380683. DOI: 10.1038/s41467-024-52159-y.


Interaction of carrier and disease isolates of MenB cc32 and MenW cc22 with epithelial cells of the nasopharyngeal barrier.

Peters S, Mohort K, Claus H, Stigloher C, Schubert-Unkmeir A Front Cell Infect Microbiol. 2024; 14:1389527.

PMID: 38756230 PMC: 11096551. DOI: 10.3389/fcimb.2024.1389527.


Characterizing the diversity and commensal origins of mosaicism in the genus .

Unitt A, Maiden M, Harrison O Microb Genom. 2024; 10(2).

PMID: 38381035 PMC: 10926701. DOI: 10.1099/mgen.0.001209.


References
1.
Russell J, Urwin R, Gray S, Fox A, Feavers I, Maiden M . Molecular epidemiology of meningococcal disease in England and Wales 1975-1995, before the introduction of serogroup C conjugate vaccines. Microbiology (Reading). 2008; 154(Pt 4):1170-1177. PMC: 2885627. DOI: 10.1099/mic.0.2007/014761-0. View

2.
Oster P, Lennon D, OHallahan J, Mulholland K, Reid S, Martin D . MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain. Vaccine. 2005; 23(17-18):2191-6. DOI: 10.1016/j.vaccine.2005.01.063. View

3.
Tinsley C, Nassif X . Meningococcal pathogenesis: at the boundary between the pre- and post-genomic eras. Curr Opin Microbiol. 2001; 4(1):47-52. DOI: 10.1016/s1369-5274(00)00163-6. View

4.
Hilse R, Stoevesandt J, Caugant D, Claus H, Frosch M, Vogel U . Distribution of the meningococcal insertion sequence IS1301 in clonal lineages of Neisseria meningitidis. Epidemiol Infect. 2000; 124(2):337-40. PMC: 2810918. DOI: 10.1017/s0950268899003647. View

5.
Jordens J, Heckels J . A novel porA-based real-time PCR for detection of meningococcal carriage. J Med Microbiol. 2005; 54(Pt 5):463-466. DOI: 10.1099/jmm.0.45847-0. View